samedan logo
 
 
 
spacer
home > pmps > autumn 2020 > the decline of cold chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Decline of Cold Chain

Cold chain services in the pharmaceutical sector are under more scrutiny than ever due to their impact on the environment and the energy-intensive nature of the technology. However, shock caused by the ongoing COVID-19 pandemic, and the potential disruption that could be inflicted by exiting the European trading bloc means that cold storage stockpiling is set to remain a huge priority for the industry. Though the UK’s cold chain infrastructure is set to come under increasing pressure, the onus is still on pharma suppliers to ensure their cold storage solutions are energy efficient and adhere to sustainability-focused legislation. This will require an innovative, strategic approach.

Stockpiling in pharma manufacturing is by no means new. The demand in flu season, for example, means manufacturers often resort to making the drugs in large batches. These products, which tend to have a shelf-life of around five years, require strict temperature control, which, in turn, requires cold chain storage services to maintain conditions and negate product spoilage. Though the industry traditionally has the capacity to store pharmaceutical products ahead of distribution, a series of pressing issues is putting this in doubt.

First and foremost among these issues is the coronavirus. As well as having a catastrophic effect on the global economy, COVID-19 has mounted pressure on the pharma sector like never before. Company stakeholders across the industry are urgently looking for ways to make processes more efficient as they fast-track clinical trials to combat the pandemic, while also having to keep up with existing demand for pharmaceutical products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Matt Watson has over 17 years of experience working at Aggreko UK and Ireland, talking to professionals about their power and cooling requirements. He has worked across a range of sectors and applications, and currently heads up a team of 11 industrial sector specialists across the UK, Ireland, and Sweden. Matt’s primary focus is on understanding the demands placed on manufacturers, such as the need to increase production, reduce costs, and ensure business continuity. He specialises in enhancing and optimising processes through the provision of tailored power, heating, cooling, and dehumidification solutions that help alleviate operational challenges across multiple industries.
spacer
Matt Watson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Loftware and NiceLabel Combine, Extend Global Leadership in Enterprise Labeling and Artwork Management

Portsmouth, NH — January 12, 2021 – Loftware, Inc., the global leader in Enterprise Labeling & Artwork Management Solutions and NiceLabel, a leading developer of label management systems today announced that they are combining under the Loftware corporate umbrella. This union gives customers and partners an expanded choice of solutions, while providing enhanced labeling capabilities and the benefits of greater investment in cloud-based solutions and technologies. It also brings together 60 years of combined expertise in solving labeling challenges for companies of all sizes throughout a wide range of industries across the globe.
More info >>

White Papers

Role of Comparators in Clinical Trial Supply

Clinical Services International

CSI analyses the role of comparators in different trial designs and offers expert advice on robust methodology for choosing the most appropriate comparators. Case studies provide real insight on how to choose comparators for rare diseases and oncology studies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement